This inventor holds 5 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignee: Ajinomoto Co., Ltd.. Active years: 2003-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2010
Title: Kenji Takehana: Innovator in Biomedical and Pharmaceutical Technologies
Introduction
Kenji Takehana, an esteemed inventor based in Kawasaki, Japan, has made significant contributions to the fields of biomedical and pharmaceutical technologies. With a remarkable portfolio of five patents, his innovative work continues to address pressing health issues and advance medical research.
Latest Patents
Among Takehana's latest patents is a groundbreaking method for analyzing albumin in sample solutions. This invention provides a detailed approach, highlighting the importance of sample pretreatment before utilizing mass spectrometry or liquid chromatography. It ensures accurate and stable analysis of both oxidized and reduced albumin, alongside a standard for quantitative analysis.
Another notable patent involves benzene derivatives and their pharmaceutical applications. His research presents a variety of uses for these derivatives, including their role as inhibitors in AP-1 and NF-kappa B activation, and treating conditions such as cancer metastasis, arteriosclerosis, and inflammatory responses. These innovations hold potential for developing effective therapies across a range of medical conditions.
Career Highlights
Kenji Takehana is currently employed at Ajinomoto Co., Ltd., where he continues his research and development efforts. His expertise in inventing solutions that address critical health challenges showcases his dedication to improving patient outcomes through innovative science.
Collaborations
During his career, Takehana has collaborated with notable colleagues such as Yukio Iino and Tsuyoshi Kobayashi. These partnerships have likely contributed to the advancement of his patent work, facilitating the exchange of ideas and expertise in research.
Conclusion
Kenji Takehana exemplifies the role of an inventor dedicated to enhancing healthcare through innovative methods and pharmaceutical developments. His patents not only exhibit his ingenuity but also reflect a commitment to finding solutions that can significantly impact patient care. As he continues his work at Ajinomoto Co., Ltd., the scientific community eagerly anticipates the further advancements he will bring to the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile